CorMedix Inc. (CRMD) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for CorMedix Inc. (CRMD): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 87/100 — a percentile rank of CorMedix Inc.’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $578.3M |
| P / E | 3.1× |
| P / S | 1.2× |
| EV / EBITDA | 1.3× |
| Gross margin | 82.8% |
| Operating margin | 46.9% |
| Net margin | 40.5% |
| Return on equity | 40.6% |
| ROIC | 97.7% |
| Revenue growth | 280.5% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is CorMedix Inc. overvalued? P/S looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from CorMedix Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact